TrialBMC psychiatry2018

N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.

Chenghao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.